Under the collaboration Foundation Medicine will use its genomic sequencing and analytical capabilities to assess potentially relevant molec...
You must be logged in to view the whole article.
Click here if you require signing up
GlaxoSmithKline's Phase IIa trial of GSK2586184 in chronic plaque psoriasis meets primary goal
Impax introduces generic RENVELA in the market
CollabRx to optimise GVA Service for use with Affymetrix's OncoScan, CytoScan assays
Dr Reddy's reports availability of FDA approved Eszopiclone tablets C-IV
LifeLabs Medical Laboratory Services, Contextual Genomics ink co-marketing, testing deal
Astellas Pharma US, DOJ agree to resolve civil claims regarding Mycamine marketing
Akebia Therapeutics completes enrolment of 200 patients in Phase IIb study of AKB-6548
Medac Pharma receives FDA approval for Rasuvo trade name for injectable methotrexate
Prosonix signs global licensing agreement with Mylan
RainTree Oncology Services and Information Builders launches OncoExplorer
Prestige Brands Holdings to acquire Hydralyte in Australia and New Zealand
Chugai to introduce HER2-targeted antibody drug conjugate Kadcyla in Japan on Apr 18